A joint study by multiple laboratories in two Hong Kong universities found a broadly neutralizing antibody ZCB11. Isolated from local mRNA vaccine recipients, ZCB11 showed potent antiviral activity against all SARS-CoV-2 variants of concern. In live virus challenge experiments, administration of ZCB11 protects from lung infection by Omicron in golden Syrian hamsters. In this study,…